Supplementary Figure 7 from Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure 7. OS outcomes based on TP53 mutation, allelic status, and VAF.
Authors: Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni, David A. Sallman, Qianxing Mo, Onyee Chan, Ling Zhang, Nicole D. Vincelette, Xiaoqing Yu, Rinzine Sammut, Jungwon Moon, Junyoung Park, Sura-Attha Umasangtongkul, Felyschia M. Lledo, Tiffany N. Razabdouski, Chia-Ho Cheng, Dahui Qin, Kathy Mai, Somedeb Ball, Rory M. Shallis, Zhuoer Xie, Andrew T. Kuykendall, Eric Padron, Kendra Sweet, Alison R. Walker, Rami S. Komrokji, Jeffrey E. Lancet, Sandrine Niyongere, Thomas Cluzeau, Seongseok Yun
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7164994580